SI
PDLI

Stephens Inc’s PDL BioPharma, Inc. PDLI Stock Holding History

Stephens Inc’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-69,530
Closed -$519K – 884
2014
Q3 		$519K Buy
+69,530
New +$646K 0.03% 477
2014
Q1 		– Sell
-53,635
Closed -$453K – 960
2013
Q4 		$453K Hold
53,635
– – 0.02% 539
2013
Q3 		$427K Sell
53,635
-1,270
-2% -$10.2K 0.02% 512
2013
Q2 		$424K Buy
+54,905
New +$428K 0.02% 464

Other funds holding PDLI

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stephens Inc's PDLI Position: Q4 2014 in Review

Stephens Inc sold out of PDL BioPharma, Inc. (PDLI) in Q4 2014, closing a stake of 69,530 shares — an estimated $519K sold.

Stephens Inc first reported a position in PDLI in Q2 2013 and held it in 4 quarters. The position peaked at $519K in Q3 2014. 223 funds tracked by Wall St. Rank hold PDLI as of Q4 2014.

  • Stephens Inc reported no remaining PDL BioPharma, Inc. position as of Q4 2014 after selling out during the quarter.
  • Stephens Inc sold 69,530 PDL BioPharma, Inc. shares in Q4 2014, an estimated $519K.
  • Stephens Inc first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 4 quarters.
  • Stephens Inc's PDL BioPharma, Inc. position peaked at $519K in Q3 2014.
  • 223 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2014.

Based on Stephens Inc's 13F filing for Q4 2014, filed 12 Feb 2015.